Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effect of Artemisinin-based Combination Therapies on Urinary Schistosoma Haematobium When Administered for the Treatment of Malaria Co-infection

NCT04264130 is registered in ClinicalTrials.gov with Centre de Recherche Médicale de Lambaréné as lead sponsor.

NCT NCT04264130
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04264130 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effect of Artemisinin-based Combination Therapies on Urinary Schistosoma Haematobium When Administered for the Treatment of Malaria Co-infection
Lead sponsor
Centre de Recherche Médicale de Lambaréné
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2018
Completion date
December 31, 2019
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schistosomiasis haematobia